Passive

iShares Global Healthcare ETF

The iShares Global Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of global equities in the healthcare sector.

$87.75

+3.9% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Global Healthcare ETF IXJ
Fund Size
$4.1 Billion
Dividend
1.4%
Fees
0.40%
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.4%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.4%
Fees
0.03%
View 1287 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $219 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.64 %
Beta Indicates the relationship between the price performance of a share and the market. 0.5036
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 80.15
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -2.71
Profitable Companies 88
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 321.28
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.96
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 11.32
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 33.85
Enterprise Value to Revenue Enterprise value divided by revenue 6.37
Total Debt to Enterprise Value Total debt divided by enterprise value 0.14
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.0398
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 14.46%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 19.70%
Return on Assets Indicates a company's profitability in relation to its total assets. 7.93%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 14.34%

Industries

Healthcare 61.5%
Finance 5.1%
Industrials 4.3%
Technology 1.7%
Other 0.9%
N/A 26.5%

Market cap

Micro Cap 0%
Small Cap 0%
Mid Cap 1%
Large Cap 56%
Mega Cap 44%

117 Investments

P/E-Ratio
Total Investment
Weight
UnitedHealth Group Inc logo

UNH - Finance and Insurance

UnitedHealth Group Inc

P/E-Ratio
20.3
Total Investment
$276 Million
Weight
6.8%
Eli Lilly & Co logo

LLY - Manufacturing

Eli Lilly & Co

P/E-Ratio
135.3
Total Investment
$264 Million
Weight
6.5%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
10.0
Total Investment
$214 Million
Weight
5.3%
Novo Nordisk A/S logo

NVO - Manufacturing

Novo Nordisk A/S

P/E-Ratio
0.0
Total Investment
$190 Million
Weight
4.7%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
869.1
Total Investment
$157 Million
Weight
3.9%
AbbVie Inc logo

ABBV - Manufacturing

AbbVie Inc

P/E-Ratio
60.5
Total Investment
$155 Million
Weight
3.8%
Novartis AG logo

NVS - Health Technology

Novartis AG

P/E-Ratio
13.7
Total Investment
$119 Million
Weight
2.9%
AstraZeneca PLC logo

AZN - Health Technology

AstraZeneca PLC

P/E-Ratio
35.6
Total Investment
$119 Million
Weight
2.9%
Thermo Fisher Scientific Inc logo

TMO - Professional, Scientific, and Technical Services

Thermo Fisher Scientific Inc

P/E-Ratio
34.5
Total Investment
$116 Million
Weight
2.9%
Roche Holding AG logo

RHHVF - Health Technology

Roche Holding AG

P/E-Ratio
12.6
Total Investment
$116 Million
Weight
2.9%
Abbott Laboratories logo

ABT - Manufacturing

Abbott Laboratories

P/E-Ratio
31.9
Total Investment
$108 Million
Weight
2.7%
Pfizer Inc logo

PFE - Manufacturing

Pfizer Inc

P/E-Ratio
67.9
Total Investment
$92.2 Million
Weight
2.3%
Amgen Inc logo

AMGN - Manufacturing

Amgen Inc

P/E-Ratio
21.0
Total Investment
$87.4 Million
Weight
2.2%
Danaher Corp logo

DHR - Manufacturing

Danaher Corp

P/E-Ratio
36.9
Total Investment
$86.3 Million
Weight
2.1%
Intuitive Surgical Inc logo

ISRG - Manufacturing

Intuitive Surgical Inc

P/E-Ratio
73.5
Total Investment
$67.4 Million
Weight
1.7%
Elevance Health Inc logo

ANTM - Finance and Insurance

Elevance Health Inc

P/E-Ratio
18.6
Total Investment
$62.9 Million
Weight
1.6%
Sanofi SA logo

SNY - Health Technology

Sanofi SA

P/E-Ratio
19.2
Total Investment
$62.7 Million
Weight
1.6%
Medtronic PLC logo

Medtronic PLC

P/E-Ratio
n/a
Total Investment
$62.2 Million
Weight
1.5%
Vertex Pharmaceuticals Inc logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

P/E-Ratio
28.1
Total Investment
$59.5 Million
Weight
1.5%
Bristol-Myers Squibb Co logo

BMY - Manufacturing

Bristol-Myers Squibb Co

P/E-Ratio
12.4
Total Investment
$59.2 Million
Weight
1.5%
CVS Health Corp logo

CVS - Retail Trade

CVS Health Corp

P/E-Ratio
10.4
Total Investment
$57.5 Million
Weight
1.4%
Stryker Corp logo

SYK - Manufacturing

Stryker Corp

P/E-Ratio
39.4
Total Investment
$57.4 Million
Weight
1.4%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
14.5
Total Investment
$57.3 Million
Weight
1.4%
CSL Ltd logo

CSLLY - Professional, Scientific, and Technical Services

CSL Ltd

P/E-Ratio
0.0
Total Investment
$53.4 Million
Weight
1.3%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
24.4
Total Investment
$53.4 Million
Weight
1.3%